Today, the CSO of XBiotech (XBIT), Sushma Shivaswamy, sold shares of XBIT for $45K.
In addition to Sushma Shivaswamy, 2 other XBIT executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Currently, XBiotech has an average volume of 209.8K.
In the last 30 days, insiders have sold $45K worth of XBIT shares and purchased $1.42M worth of XBIT shares. The insider sentiment on XBiotech has been positive according to 15 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
XBiotech, Inc. is a biopharmaceutical company, which engages in discovering and developing True Human monoclonal antibodies for treating diseases. It offers MABp1, which targets and neutralizes interleukin-1 alpha, a molecule known to promote angiogenesis, growth and spread of tumors, as well as mediate symptoms such as metabolic dysregulation, fatigue, and anxiety associated with advanced cancer. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.
